Don Eslin
Pediatric Hematology-Oncology · Tampa, FLNPI 1659344463
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), food and beverage and education — rather than concentrated in one kind of arrangement. USWM, LLC accounts for 61.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $3,435 and has fallen 81.9% since, to $622 in 2025.
Across 60 payments — averaging $83.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- USWM, LLC$3K
- Novartis$429
- Astellas Pharma US Inc$321
- AstraZeneca$282
- Genentech USA, Inc.$137
- Y-mabs Therapeutics, Inc.$130
- plus $620 from 13 others
Across 22 payments — averaging $20,639 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$419K
- Global Blood Therapeutics, Inc.$18K
- AbbVie$11K
- Incyte Corporation$4K
- E.r. Squibb & Sons, L.L.C.$1K
What the payments were for
- Speaking & faculty fees$2,98059%
- Food & beverage$1,91838%
- Education$1132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| USWM, LLC | 6 | $3,091 |
| Novartis | 12 | $429 |
| Astellas Pharma US Inc | 6 | $321 |
| AstraZeneca(2 entities) | 9 | $282 |
| Genentech USA, Inc. | 2 | $137 |
| Y-mabs Therapeutics, Inc. | 2 | $130 |
| Amgen | 2 | $107 |
| Jazz Pharmaceuticals Inc. | 4 | $107 |
| Springworks Therapeutics, Inc. | 4 | $100 |
| Pfizer | 2 | $65 |
| Global Blood Therapeutics, Inc. | 2 | $42 |
| Bayer | 2 | $42 |
| Day One Biopharmaceuticals | 1 | $30 |
| Novo Nordisk | 1 | $22 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| Genentech, Inc. | 1 | $22 |
| RARE Disease Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,011 in reported general payments places this provider in the 75th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Tampa
- Erin CockrellTampa$260K
- Dana ObzutTampa$93K
- Damon ReedTampa$9K
- Trisha LarkinTampa$4K
- Simone ChangTampa$2K
- Juan RicoTampa$1K
- Deepakbabu ChellapandianTampa$1K
- Diana LoneTampa$1K
- Guillermo DeanguloMiami$929K
- Shveta GuptaOrlando$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.